ClinicalTrials.Veeva

Menu

Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy

Fudan University logo

Fudan University

Status and phase

Unknown
Phase 3

Conditions

Esophageal Cancer

Treatments

Procedure: Discharge the NG tube during the surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT03273686
ESO-NGT

Details and patient eligibility

About

Nasogastric decompression is standard practice after esophageal resection in most centers because it is expected to reduce the incidence of esophagogastric anastomotic leakage by preventing overdistension of the gastric conduit. Most esophageal surgeons have been reluctant to move away from this tradition because of the considerable morbidity of anastomotic leaks after esophagectomy. However, a contrarian view is that the use of prolonged NGD may increase the incidence of postoperative pulmonary complications by promoting aspiration. Considering the numerous complications caused by using the tube and the uncertainty about its usefulness and the scarcity of studies conducted on the subject, particularly in patients with esophageal cancer, the necessity of using the tube in these types of cases is investigated in the present study.

Full description

Methods In this clinical trial, patients with esophageal cancer were randomized into groups with NG tube and without NG tube after surgery. Sequence generation was performed using a computer-generated sequence of random numbers with permuted blocks. Standard postoperative management protocols were followed in both groups to avoid potential bias, which including preoperation nasogastric decompression. Thoracic esophageal mobilization and mediastinal lymphadenectomy were performed by open thoracotomy surgery. The abdominal part of the surgery was performed by laparotomy, gastric tube reconstruction was performed using linear staplers, and the conduit was brought up to the neck through the posterior mediastinal route. A cervical esophagogastric anastomosis was performed by stapled (linear) techniques. All patients were mobilized early, began early enteral feeding through jejunostomy tubes. Randomization was performed during the surgery. The group without NG tube after surgery will discharge the NG tube during the surgery. While the control group(group with NG tube after surgery) will discharge the NG tube 6-7days after surgery. The variables recorded for each patient included pulmonary complications, wound complications, anastomosis leak as well as the duration of postoperative hospitalization and the need for placing replacing the NG tube.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients who were fit for esophageal resection and underwent transthoracic or transhiatal esophagectomy with gastric tube reconstruction.

Exclusion criteria

  1. Stage investigations indicating unresectable advanced disease(T4 or M1a,M1b).
  2. Patients with any other serious underlying medical condition that would impair the ability of the patient to receive or comply with protocol treatment.
  3. Patients with unstable situation after surgery (eg, need ventilation and ICU treatment)
  4. Patients medically unfit for surgical resection.
  5. Patients with pulmonary reserve inadequate to undergo thoracotomy and extensive mediastinal lymphadenectomy.
  6. Mentally disabled.
  7. Expected life duration of less than 3 months.
  8. Patients undergoing colonic reconstruction.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

group without NG tube after surgery
Experimental group
Description:
In this goup, patients will undergo preoperative gastrointestinal decompression and investigators will discharge the NG tube during the surgery.
Treatment:
Procedure: Discharge the NG tube during the surgery
group with NG tube after surgery
No Intervention group
Description:
In this goup, patients will undergo preoperative gastrointestinal decompression and investigators will discharge the NG tube 6-7 days after the surgery.

Trial contacts and locations

0

Loading...

Central trial contact

Yiliang Zhang, MD; Jiaqing Xiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems